3,5-Dimethylisoxazole-4-sulfonamide → HCID 72613060, compound

HRID 2181099Notes

Reaction equation

HRID 2181099 reaction equation
CC1(C)[O:6][C:5](=[CH:7][C:8]([N:10]([CH2:13][C:14]2[CH:19]=[CH:18][C:17]([F:20])=[CH:16][CH:15]=2)[O:11][CH3:12])=[O:9])[C:4](=[O:21])O1.[CH3:23][C:24]1[C:28]([S:29]([NH2:32])(=[O:31])=[O:30])=[C:27]([CH3:33])[O:26][N:25]=1>>[F:20][C:17]1[CH:16]=[CH:15][C:14]([CH2:13][N:10]([O:11][CH3:12])[C:8](=[O:9])[CH:7]=[C:5]([OH:6])[C:4]([NH:32][S:29]([C:28]2[C:24]([CH3:23])=[N:25][O:26][C:27]=2[CH3:33])(=[O:30])=[O:31])=[O:21])=[CH:19][CH:18]=1

Participants

3

Procedure

2-(2,2-Dimethyl-5-oxo-[1,3]dioxolan-4-ylidene)-N-(4-fluoro-benzyl)-N-methoxy-acetamide was treated with 3,5-dimethyl-isoxazole-4-sulfonic acid amide as described in the preparation of compound 1 to yield the title compound. LCMS (M+H) calcd for C17H19FN3O7S: 428.1; found: 428.0. 1H NMR (500 MHz, CDCl3) δ: 2.44 (s, 3), 2.75 (s, 3), 3.65 (s, 3), 4.77 (s, 2), 6.45 (s, 1), 7.01 (m, 2), 7.26 (m, 2). 13C NMR (125 MHz, CDCl3) δ:10.83, 13.24, 48.33, 63.23, 92.57, 114.23, 115.71, 115.89, 130.19, 130.29, 130.96, 157.85, 158.89, 159.44, 161.71, 163.68, 170.81, 177.09.

Sources & evidence

ORD record
ord-d729bd5b582b42238cec8b5c57ce42e2
Source dataset
uspto-grants-2005_05
Patent number
US06890942B2

Reaction notes

Loading…